Visudyne verteporfin: Long-term data; marketed
In a 3-year, open-label extension to 2, 2-year double-blinded, placebo-controlled, international Phase
Gathering data...
In a 3-year, open-label extension to 2, 2-year double-blinded, placebo-controlled, international Phase